Correlation Between 89bio and Oncolytics Biotech
Can any of the company-specific risk be diversified away by investing in both 89bio and Oncolytics Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 89bio and Oncolytics Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 89bio Inc and Oncolytics Biotech, you can compare the effects of market volatilities on 89bio and Oncolytics Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 89bio with a short position of Oncolytics Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of 89bio and Oncolytics Biotech.
Diversification Opportunities for 89bio and Oncolytics Biotech
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between 89bio and Oncolytics is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding 89bio Inc and Oncolytics Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncolytics Biotech and 89bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 89bio Inc are associated (or correlated) with Oncolytics Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncolytics Biotech has no effect on the direction of 89bio i.e., 89bio and Oncolytics Biotech go up and down completely randomly.
Pair Corralation between 89bio and Oncolytics Biotech
Given the investment horizon of 90 days 89bio Inc is expected to generate 0.97 times more return on investment than Oncolytics Biotech. However, 89bio Inc is 1.03 times less risky than Oncolytics Biotech. It trades about 0.01 of its potential returns per unit of risk. Oncolytics Biotech is currently generating about -0.01 per unit of risk. If you would invest 1,035 in 89bio Inc on September 5, 2024 and sell it today you would lose (205.00) from holding 89bio Inc or give up 19.81% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
89bio Inc vs. Oncolytics Biotech
Performance |
| Timeline |
| 89bio Inc |
| Oncolytics Biotech |
89bio and Oncolytics Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 89bio and Oncolytics Biotech
The main advantage of trading using opposite 89bio and Oncolytics Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 89bio position performs unexpectedly, Oncolytics Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncolytics Biotech will offset losses from the drop in Oncolytics Biotech's long position.| 89bio vs. Candel Therapeutics | 89bio vs. Cingulate Warrants | 89bio vs. Unicycive Therapeutics | 89bio vs. Cardio Diagnostics Holdings |
| Oncolytics Biotech vs. Candel Therapeutics | Oncolytics Biotech vs. Cingulate Warrants | Oncolytics Biotech vs. Unicycive Therapeutics | Oncolytics Biotech vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |